Otsuka Holdings Co., Ltd. (4578.T) JPX

Currency In JPY

AD

Otsuka Holdings Co., Ltd.

Address

2-9 Kanda-Tsukasamachi

Tokyo, TKY 101-0048

Japan

Phone

81 3 6717 1410

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

37758

First IPO Date

December 15, 2010

Key Executives

NameTitlePayYear Born
Makoto InouePresident, Chief Executive Officer & Representative Director214M1958
Yuko MakinoChief Financial Officer & Executive Director67M1961
Shuichi TakagiExecutive Director109M1966
Noriko TojoExecutive Director109M1964
Masayuki KobayashiExecutive Director109M1966
Yoshiro MatsuoExecutive Deputy President & Representative Director156M1960
Manabu KawataExecutive Vice President & Operating Officer of Business Development Department0N/A
Chiaki SakuraiSenior EVice President, Operating Officer & Dir. of Nutraceutical Bus., Global Strat. and Planning Headquarters0N/A
Keiso YamasakiExecutive Vice President, Operating Officer & Director of Corporation Planning Dept., Bus. Insights and Analytics0N/A
Tomohiro EmuraExecutive Vice President & Operating Officer of IR, Public Relations, and Sustainability Promotion0N/A
AD

Description

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.

AD